Vimarsana
Biggest News Aggregation in the World

Page 4 - While Enzolytics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from While Enzolytics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In While Enzolytics Inc Today - Breaking & Trending Today

Enzolytics, Inc. Announces U.S. Distribution of IPF Immune and Progress in each of its Therapeutic Platforms - Vimarsana News

Enzolytics, Inc. Announces U.S. Distribution of IPF Immune and Progress in each of its Therapeutic Platforms

COLLEGE STATION, TX / ACCESSWIRE / December 13, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Enzolytics' focus is on the production and distribution of the Company's therapeutics and

Enzolytics, Inc.: Enzolytics Recognizes World AIDS Day and Highlights the Company's Focus on Producing Effective Therapies for Treating HIV - Vimarsana News

Enzolytics, Inc.: Enzolytics Recognizes World AIDS Day and Highlights the Company's Focus on Producing Effective Therapies for Treating HIV

COLLEGE STATION, TX / ACCESSWIRE / December 1, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).World AIDS Day has been recognized on this day since 1988. It is an important day for the

Enzolytics, Inc.: Enzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Study - Vimarsana News

Enzolytics, Inc.: Enzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Study

COLLEGE STATION, TX / ACCESSWIRE / October 5, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) ("ENZC" or the "Company"). The Company announces the completion of the first phase of the animal toxicology studies

Enzolytics, Inc.: Enzolytics Announces the Discovery of Conserved Target Sites on the Monkeypox Virus - Vimarsana News

Enzolytics, Inc.: Enzolytics Announces the Discovery of Conserved Target Sites on the Monkeypox Virus

COLLEGE STATION, TX / ACCESSWIRE / June 21, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (ENZC" or the "Company") today announced it has identified conserved, immutable sites (epitopes) on the Monkeypox virus.

Enzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day Podcast - Vimarsana News

Enzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day Podcast

The Stock Day Podcast welcomed Enzolytics, Inc. , a drug development company committed to commercializing its proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases.... | May 16, 2022